What is Ocular Science?
Founded in 2015 and headquartered in El Segundo, California, Ocular Science is dedicated to developing innovative, user-friendly, and cost-effective solutions for the corrective eye care industry. The company leverages a robust medical advisory board of 30 leading ophthalmology experts to guide its development of paradigm-shifting therapeutic products. Ocular Science aims to enhance patient compliance and provide advanced eye care options for both physicians and patients, positioning itself as a key player in the burgeoning medtech sector.
How much funding has Ocular Science raised?
Ocular Science has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Ocular Science
PPP
Public-Private Partnership
What's next for Ocular Science?
With the recent influx of capital from a major strategic investment, Ocular Science is poised for significant expansion and further product development. This large-scale, late-stage funding suggests a focus on scaling operations, potentially entering new markets, and accelerating the commercialization of its pipeline. The company's commitment to affordability and patient compliance, backed by a strong medical advisory board, indicates a strategic direction aimed at capturing substantial market share in the corrective eye care industry.
See full Ocular Science company page
